U.S., March 4 -- ClinicalTrials.gov registry received information related to the study (NCT06854029) titled 'NOTRE: Optimizing Long-Acting Pre-Exposure Prophylaxis and Medications for Opioid Use Disorder Interventions in Carceral Settings' on Feb. 25.
Brief Summary: The investigators plan to conduct an R61/33 hybrid type 2 implementation-effectiveness trial that includes 1) a one-year exploratory R61 phase that will enable the development of the intervention protocol needed for the R33 trial phase including concrete R61 phase milestones; 2) a four-year R33 phase that will include a concurrent implementation evaluation and a randomized control trial.
Study Start Date: Nov., 2025
Study Type: INTERVENTIONAL
Condition:
HIV Infections
Opioi...